Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Paper
  • Published:

Downregulation of MMP-9 in ERK-mutated stable transfectants inhibits glioma invasion in vitro

Abstract

We previously showed that enhanced expression of MMP-9, an endopeptidase that digests basement-membrane type IV collagen, is related to tumor progression in vitro and in vivo; antisense-MMP-9 stably transfected clones were less invasive than untransfected parental cells and did not form tumors in nude mice. In this study, we examined the role of ERK-1 in the regulation of MMP-9 production and the invasive behavior of the human glioblastoma cell line SNB19, in which ERK1 is constitutively activated. SNB19 cells were stably transfected with mt-ERK, a vector encoding ERK-1 cDNA in which the conserved lysine at codon 71 was changed to arginine, thus impairing the catalytic efficiency of this enzyme. Gelatin zymography showed reduced levels of MMP-9 in the mt-ERK-transfected cell lines relative to those in vector-transfected and parental control cells. Reductions in MMP-9 protein mRNA levels were also detected in the mt-ERK-transfected cells by Western and Northern blotting. The mt-ERK-transfected cells were much less invasive than parental or vector control cells in a Matrigel invasion assay and in a spheroid coculture assay. Thus an ERK-dependent signaling pathway seems to regulate MMP-9 mediated glioma invasion in SNB19 cells; interfering with this pathway could be developed into a therapeutic approach, which aims at a reduction of cancer cell invasion.

This is a preview of subscription content, access via your institution

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6
Figure 7

Similar content being viewed by others

References

  • Agarwal S, Corbley MJ, Roberts TM . 1995 Oncogene 11: 427–438

  • Bogoyevitch MA, Ketterman AJ, Sugden PH . 1995 J. Biol. Chem. 270: 29710–29717

  • Bond M, Chase AJ, Baker AH, Newby AC . 2001 CardVas. Res. 50: 556–565

  • Bond M, Fabunmi RP, Baker AH, Newby AC . 1998 FEBS Letts. 435: 29–34

  • Cavigelli M, Dolfi F, Claret F, Karin M . 1995 EMBO J. 14: 5957–5964

  • Chaturvedi MM, LaPushin R, Aggarwal BB . 1994 J. Biol. Chem. 269: 14575–14583

  • Chen Q, Kinch MS, Lin TH, Burridge K, Juliano RL . 1994 J. Biol. Chem. 6: 26602–26605

  • Chintala SK, Sawaya R, Aggarwal BB, Majumder S, Giri DK, Kyritsis AP, Gokaslan ZL, Rao JS . 1998 J. Biol. Chem. 273: 13545–13551

  • Derijard B, Hibi M, Wu IM, Barrett T, Su B, Deng T, Karim M, Davis RJ . 1994 Cell 76: 1025–1037

  • Forsyth PA, Dickinson-Laing T, Gibson A, Rewcastle NB, Sutherland G, Johnston R . 1998 J. Neuro-Oncol. 36: 21–29

  • Frost JA, Geppert TD, Cobb MH, Feramisco JR . 1994 Proc. Natl. Acad. Sci. USA 91: 3844–3848

  • Genersch E, Hayess K, Nuenfeld Y, Haller H . 2000 J. Cell Sci. 113: 4319–4330

  • Go Y, Chintala SK, Mohanam S, Gokaslan ZL, Bjerkvig R, Oka K, Nicolson GL, Sawaya R, Rao JS . 1997 Clin. Exp. Metastasis 15: 440–446

  • Gum R, Lengyel E, Juarez J, Chen JH, Sato H, Seiki M, Boyd D . 1996 J. Biol. Chem. 271: 10672–10682

  • Gum R, Wang H, Lengyel E, Juarez J, Boyd D . 1997 Oncogene 14: 1481–1493

  • Huang S, Pettaway CA, Uehara H, Bucana CD, Fidler IJ . 2001 Oncogene 20: 4188–4197

  • Karin M, Liu ZG, Zandi E . 1997 Curr. Opin. Cell Biol. 9: 24–246

  • Kondraganti S, Mohanam S, Chintala SK, Kin Y, Jasti SL, Chandrasekar N, Lakka SS, Adachi Y, Kyritsis AP, Ali-Osman F, Sawaya R, Fuller GN, Rao JS . 2000 Cancer Res. 60: 6851–6855

  • Lakka SS, Jasti SL, Kyritsis AP, Yung WKA, Ali-Osman F, Rao JS . 2000 Clin. Exp. Metastasis 18: 245–252

  • Li S, Sedivy JM . 1993 Proc. Natl. Acad. Sci. USA 90: 9247–9251

  • Matrisian LM . 1992 Bioessays 14: 455–463

  • McCawley LJ, Li S, Wattenberg EV, Hudson LG . 1999 J. Biol. Chem. 274: 4337–4353

  • Mohanam S, Sawaya R, McCutcheon I, Ali-Osman F, Boyd D, Rao JS . 1993 Cancer Res. 53: 4143–4147

  • Nakada M, Nakamura H, Ikeda E, Fujimoto N, Yamashita J, Sato H, Seiki M, Okada Y . 1999 Am. J. Pathol. 154: 417–428

  • Rao JS, Steck PA, Mohanam S, Stetler-Stevenson WG, Liotta LA, Sawaya R . 1993 Cancer Res. 53: 2208–2211

  • Rao JS, Yamamoto M, Mohanam S, Gokaslan ZL, Stetler-Stevenson WG, Rao VH, Fuller GN, Liotta LA, Nicholson GL, Sawaya R . 1996 Clin. Exp. Metastasis 14: 12–18

  • Robinson MJ, Cobb MH . 1997 Curr. Opin. Cell Biol. 9: 180–186

  • Sato H, Kita M, Seiki M . 1993 J. Biol. Chem. 268: 23460–23468

  • Sato H, Seiki M . 1993 Oncogene 8: 395–405

  • Schreiber E, Matthias P, Muller MM, Schaffner W . 1989 Nucleic Acids Res. 17: 6419

  • Simon C, Goepfert H, Boyd D . 1998 Cancer Res. 58: 1135–1139

  • Simon C, Simon M, Vucelic G, Hicks MJ, Plinkert PK, Koitschev A, Zenner P . 2001 Exp. Cell. Res. 271: 344–355

  • Smeal T, Angel P, Meek J, Karin M . 1989 Genes Dev. 3: 2091–2100

  • Sozeri O, Vollmer K, Liyanage M, Frith D, Kour G, Mark III GE, Stabel S . 1992 Oncogene 11: 2259–2262

  • Whisler RL, Chen M, Beiquing L, Carle KW . 1997 Cell Immunol. 175: 41–50

  • Wilhelm SM, Collier IE, Marmer BL, Eisen AZ, Grant G, Goldberg G . 1989 J. Biol. Chem. 264: 17213–17221

  • Yao J, Xiong S, Klos K, Nguyen N, Grijalva R, Li P, Yu D . 2001 Oncogene 20: 8066–8074

  • Zeigler ME, Chi Y, Schmidt T, Varani J . 1999 J. Cell Physiol. 18: 271–284

Download references

Acknowledgements

Supported by National Cancer Institute Grants CA-76350, CA-75557 and CA-85216 (JS Rao).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Jasti S Rao.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lakka, S., Jasti, S., Gondi, C. et al. Downregulation of MMP-9 in ERK-mutated stable transfectants inhibits glioma invasion in vitro. Oncogene 21, 5601–5608 (2002). https://doi.org/10.1038/sj.onc.1205646

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1205646

Keywords

This article is cited by

Search

Quick links